Intranasal Drug Delivery: How, Why and What for?
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
Over the last decade the interest in intranasal delivery as a non-invasive route for drug administration has been exponentially increased. Since the nasal mucosa offers numerous benefits as a target issue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. The present paper reviews the relevant aspects of nasal anatomy, physiology and histology, and refers to the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation in appropriate nasal pharmaceutical formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is non-invasive, painless, non-stressful, and relatively easy to perform without requiring a medical specialist [246,247,248].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [248]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Abramson, M. H. (1996) · The Endocrinologist · doi:10.1097/00019616-199603000-00014 · Cited by 1,400
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,190
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
Illum, L., Farraj, N. F., & Davis, S. S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018901302450 · Cited by 629
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
UGWOKE, M., AGU, R., VERBEKE, N., & KINGET, R. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.009 · Cited by 543
Nasal mucociliary clearance as a factor in nasal drug delivery
Marttin, E., Schipper, N. G. M., Verhoef, J. C., & Merkus, F. W. H. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00059-8 · Cited by 469
Blood-brain barrier biology and methodology
Pardridge, W. M. (1999) · Journal of Neurovirology · doi:10.3109/13550289909021285 · Cited by 445
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 431
Permeability issues in nasal drug delivery
Arora, P., Sharma, S., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02452-2 · Cited by 426
Regulation of mucociliary clearance in health and disease
Houtmeyers, E., Gosselink, R., Gayan-Ramirez, G., & Decramer, M. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13e39.x · Cited by 422
Penetration and enzymatic barriers to peptide and protein absorption
Lee, V. H. L., & Yamamoto, A. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90018-5 · Cited by 413
Chemical Aspects of Selective Toxicity
ALBERT, A. (1958) · Nature · doi:10.1038/182421a0 · Cited by 401
Differentiated structure and function of cultures from human tracheal epithelium
Yamaya, M., Finkbeiner, W. E., Chun, S. Y., & Widdicombe, J. H. (1992) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1992.262.6.l713 · Cited by 361
McMartin, C., Hutchinson, L. E. F., Hyde, R., & Peters, G. E. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760709 · Cited by 349
Anatomy, physiology and function of the nasal cavities in health and disease
Mygind, N., & Dahl, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00058-6 · Cited by 344
CHITOSAN NANOPARTICLES: A PROMISING SYSTEM FOR DRUG DELIVERY
Tiyaboonchai, W. (2003) · Asian Health, Science and Technology Reports · Cited by 341
Effects of physicochemical properties and other factors on systemic nasal drug delivery
Behl, C. R., Pimplaskar, H. K., Sileno, A. P., deMeireles, J., & Romeo, V. D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00063-x · Cited by 312
Bernkop-Schnürch, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00204-6 · Cited by 309
Bacterial Biofilms on the Sinus Mucosa of Human Subjects With Chronic Rhinosinusitis
Sanderson, A. R., Leid, J. G., & Hunsaker, D. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000221954.05467.54 · Cited by 307
Goblet Cells Secretion and Mucogenesis
Verdugo, P. (1990) · Annual Review of Physiology · doi:10.1146/annurev.ph.52.030190.001105 · Cited by 282
Dyer, A. M., Hinchcliffe, M., Watts, P., Castile, J., Jabbal-Gill, I., Nankervis, R., Smith, A., & Illum, L. (2002) · Pharmaceutical Research · doi:10.1023/a:1016418523014 · Cited by 280
Nasal Drug Administration: Potential for Targeted Central Nervous System Delivery
Graff, C. L., & Pollack, G. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20318 · Cited by 260
Intranasal Drug Delivery for Brain Targeting
Vyas, T., Shahiwala, A., Marathe, S., & Misra, A. (2005) · Current Drug Delivery · doi:10.2174/1567201053586047 · Cited by 257
Hou, T., & Xu, X. (2002) · Journal of Molecular Modeling · doi:10.1007/s00894-002-0101-1 · Cited by 255
Drug Metabolism in the Nasal Mucosa
Sarkar, M. A. (1992) · Pharmaceutical Research · doi:10.1023/a:1018911206646 · Cited by 250
Absorption of drugs from the nasal mucosa of rat
Shinichiro, H., Takatsuka, Y., Tai, M., & Hiroyuki, M. (1981) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(81)90058-2 · Cited by 249
Nanoparticulate Systems for Nasal Delivery of Drugs: A Real Improvement over Simple Systems?
Illum, L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20718 · Cited by 237
Hou, T., Wang, J., Zhang, W., & Xu, X. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600343x · Cited by 228
Cyclodextrins in nasal drug delivery
Merkus, F. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00054-4 · Cited by 221
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
Van Kampen, K. R., Shi, Z., Gao, P., Zhang, J., Foster, K. W., Chen, D.-T., Marks, D., Elmets, C. A., & Tang, D.-C. C. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.043 · Cited by 220
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
Lee, V. H. L., Yamamoto, A., & Kompella, U. B. (1991) · PubMed · Cited by 213
The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery
Schipper, N. G. M., Verhoef, J. C., & Merkus, F. W. H. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015830907632 · Cited by 212
Safety of Inhaled and Intranasal Corticosteroids: Lessons for the New Millennium
Lipworth, B. J., & Jackson, C. M. (2000) · Drug Safety · doi:10.2165/00002018-200023010-00002 · Cited by 209
Determination of baseline human nasal pH and the effect of intranasally administered buffers
Washington, N., Steele, R. J. C., Jackson, S. J., Bush, D., Mason, J., Gill, D. A., Pitt, K., & Rawlins, D. A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00442-1 · Cited by 200
Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems
(2006) · CRC Press eBooks · doi:10.1201/9781420004137 · Cited by 195
From nose to brain: understanding transport capacity and transport rate of drugs
Wu, H., Hu, K., & Jiang, X. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.10.1159 · Cited by 188
Biocompatible Microemulsions and Their Prospective Uses in Drug Delivery
Gupta, S., & Moulik, S. P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21177 · Cited by 185
Giunchedi, P., Juliano, C., Gavini, E., Cossu, M., & Sorrenti, M. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00237-5 · Cited by 182
Ehrhardt, C., & Kim, K. (2007) · Springer eBooks · doi:10.1007/978-0-387-74901-3 · Cited by 181
Donovan, M. D., Flynn, G. L., & Amidon, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015921101465 · Cited by 178
Jung, T., Kamm, W., Breitenbach, A., Hungerer, K.-D., Hundt, E., & Kissel, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011063232257 · Cited by 177
(1956) · AIBS Bulletin · doi:10.1093/aibsbulletin/6.5.36-d · Cited by 174
Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies
GAVINI, E., HEGGE, A., RASSU, G., SANNA, V, TESTA, C., PIRISINO, G., KARLSEN, J., & GIUNCHEDI, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.013 · Cited by 170
Harris, A. S., Nilsson, I. M., G-.Wagner, Z., & Alkner, U. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600751113 · Cited by 165
Mao, S., Germershaus, O., Fischer, D., Linn, T., Schnepf, R., & Kissel, T. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8175-y · Cited by 164
Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems
Sharma, S., Mukkur, T. K. S., Benson, H. A. E., & Chen, Y. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21493 · Cited by 160
Chronic rhinosinusitis and biofilms
Ramadan, H. H., Sanclement, J. A., & Thomas, J. G. (2005) · Otolaryngology · doi:10.1016/j.otohns.2004.11.011 · Cited by 160
Borges, O., Cordeiro-da-Silva, A., Tavares, J., Santarém, N., de Sousa, A., Borchard, G., & Junginger, H. E. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.01.019 · Cited by 158
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163
Hashizume, R., Ozawa, T., Gryaznov, S. M., Bollen, A. W., Lamborn, K. R., Frey, W. H., & Deen, D. F. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-052 · Cited by 155
Salib, R. J., & Howarth, P. H. (2003) · Drug Safety · doi:10.2165/00002018-200326120-00003 · Cited by 150
Intranasal drug delivery for systemic medications.
Chien, Y. W., & Chang, S. (1987) · PubMed · Cited by 142
Topical Antimicrobials in the Management of Chronic Rhinosinusitis: A Systematic Review
Lim, M., Citardi, M. J., & Leong, J. (2008) · American Journal of Rhinology · doi:10.2500/ajr.2008.22.3189 · Cited by 141
Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats
Dufès, C., Olivier, J., Gaillard, F. P., Gaillard, A., Couet, W. R., & Jm, M. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00039-5 · Cited by 141
Pro-drugs as Novel Drug Delivery Systems
Higuchi, T., & Stella, V. J. (1975) · ACS symposium series · doi:10.1021/bk-1975-0014 · Cited by 140
Nagamoto, T., Hattori, Y., Takayama, K., & Maitani, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022414.17183.58 · Cited by 136
Desrosiers, M. Y., & Salas, M. (2001) · Otolaryngology · doi:10.1067/mhn.2001.117410 · Cited by 135
Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting
Jogani, V. V., Shah, P., Mishra, P., Mishra, A. K., & Misra, A. R. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318157205b · Cited by 134
Use of Nebulized Antibiotics for Acute Infections in Chronic Sinusitis
Vaughan, W. C., & Carvalho, G. J. (2002) · Otolaryngology · doi:10.1067/mhn.2002.129738 · Cited by 132
Kao, H. D., Traboulsi, A. A., Itoh, S., Dittert, L. W., & HUSSAIN, A. A. (2000) · Pharmaceutical Research · doi:10.1023/a:1007583422634 · Cited by 123
Characterization of the Barrier Properties of Mucosal Membranes
Corbo, D. C., Liu, J., & Chien, Y. W. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790304 · Cited by 122
Christrup, L. L., Foster, D. J. R., Popper, L., Troen, T., & Upton, R. A. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.03.001 · Cited by 120
Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies
Shao-yun, Y., Zhao, Y. H., Feng-lan, W., Zhang, X., Lü, W.-L., Zhang, H., & Zhang, Q. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.007 · Cited by 116
The use of human nasal in vitro cell systems during drug discovery and development
Dimova, S., Brewster, M., Noppe, M., Jorissen, M., & Augustijns, P. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.07.003 · Cited by 116
Rational design of nasal vaccines
Slütter, B., Hagenaars, N., & Jiskoot, W. (2008) · Journal of drug targeting · doi:10.1080/10611860701637966 · Cited by 115
Gavini, E., Rassu, G., Sanna, V., Cossu, M., & Giunchedi, P. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055623 · Cited by 114
Intranasal Delivery of Antiepileptic Medications for Treatment of Seizures
Wermeling, D. P. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.01.002 · Cited by 113
Charlton, S. T., Jones, N. S., Davis, S. S., & Illum, L. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.11.018 · Cited by 113
Recent Patents Review on Intranasal Administration for CNS Drug Delivery
Misra, A. R., Jogani, V. V., Jinturkar, K., & Vyas, T. K. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108783331429 · Cited by 112
Huang, C. H., Kimura, R., Bawarshi, R., & HUSSAIN, A. A. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740605 · Cited by 110
Debin, A., Kravtzoff, R., Santiago, J. V., Cazales, L., Spérandio, S., Melber, K., Janowicz, Z. A., Betbeder, D., & Moynier, M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00191-3 · Cited by 108
Maxillary Sinus Anatomy: A Cadaveric Study With Clinical Implications
Gosau, M., Rink, D., Driemel, O., & Draenert, F. G. (2009) · The Anatomical Record · doi:10.1002/ar.20859 · Cited by 107
Nasal Administration of Osteopontin Peptide Mimetics Confers Neuroprotection in Stroke
Doyle, K. P., Yang, T., Lessov, N. S., Ciesielski, T., Stevens, S. L., Simon, R. P., King, J. S., & Stenzel‐Poore, M. P. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.17 · Cited by 105
Sinswat, P., & Tengamnuay, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00090-5 · Cited by 105
Wang, J., Tabata, Y., & Morimoto, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.011 · Cited by 105
Huang, J., Garmise, R. J., Crowder, T. M., Mar, K. D., Hwang, C. R., Hickey, A. J., Mikszta, J. A., & Sullivan, V. J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.06.049 · Cited by 102
Effectiveness of Topical Antibiotics on Staphylococcus Aureus Biofilm in Vitro
Desrosiers, M. Y., Bendouah, Z., & Barbeau, J. (2007) · American Journal of Rhinology · doi:10.2500/ajr.2007.21.3007 · Cited by 102
Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery
Jain, A. K., Chalasani, K. B., Khar, R. K., Ahmed, F. J., & Diwan, P. V. (2007) · Journal of drug targeting · doi:10.1080/10611860701453653 · Cited by 98
Westin, U., Piras, E., Jansson, B., Bergström, U., Dahlin, M., Brittebo, E. B., & Björk, E. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.009 · Cited by 96
Towards Quantitative Prediction of Oral Drug Absorption
Dressman, J., Thelen, K., & Jantratid, E. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847100-00003 · Cited by 95
Effect of Bile Salts on Nasal Permeability In Vitro
Hersey, S. J., & Jackson, R. T. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600761206 · Cited by 93
Biotransformation Enzymes in the Rodent Nasal Mucosa: The Value of a Histochemical Approach
Bogdanffy, M. S. (1990) · Environmental Health Perspectives · doi:10.1289/ehp.85-1568341 · Cited by 92
Duchêne, D., Bochot, A., Yu, S.-C., Pépin, C., & Seiller, M. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00384-3 · Cited by 91
Fernández‐Urrusuno, R., Romani, D., Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1999) · Stp Pharma Sciences · Cited by 90
Nasal Delivery of Insulin Using Bioadhesive Chitosan Gels
Varshosaz, J., Sadrai, H., & Heidari, A. (2006) · Drug Delivery · doi:10.1080/10717540500309040 · Cited by 89
Patil, S. B., & Sawant, K. K. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802456726 · Cited by 87
Bioadhesive and formulation parameters affecting nasal absorption
Dondeti, P. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04115-x · Cited by 87
Transnasal Delivery of 5-Fluorouracil to the Brain in the Rat
Sakane, T., Yamashita, S., Yata, N., & Sezaki, H. (1999) · Journal of drug targeting · doi:10.3109/10611869909085506 · Cited by 86
Functional Evidence for P-glycoprotein at the Nose-Brain Barrier
Graff, C. L., & Pollack, G. M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9013-3 · Cited by 85
Respiratory Tract Uptake of Inhalants and Metabolism of Xenobiotics
Dahl, A. R., & Lewis, J. L. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.002123 · Cited by 83
Carbamazepine uptake into rat brain following intra-olfactory transport
Barakat, N. S., Omar, S. A., & Ahmed, A. A. E. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.1.0008 · Cited by 82
P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation
Graff, C. L., & Pollack, G. M. (2003) · Pharmaceutical Research · doi:10.1023/a:1025053115583 · Cited by 81
Drabick, J. J., Brandt, B. L., Moran, E. E., Saunders, N. B., Shoemaker, D. R., & Zollinger, W. D. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00216-9 · Cited by 81
Prodrugs for nasal drug delivery
Krishnamoorthy, R., & Mitra, A. K. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00065-3 · Cited by 77
Kaur, P., & Kim, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.030 · Cited by 77
Kimbell, J. S., Gross, E. A., Richardson, R. B., Conolly, R. B., & Morgan, K. T. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00132-2 · Cited by 75
Nasal Delivery of Antimigraine Drugs: Clinical Rationale and Evidence Base
Rapoport, A. M., & Winner, P. K. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00603.x · Cited by 73
Mechanism of nasal absorption of drugs.
Aa, H. (1989) · PubMed · Cited by 73
Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems
Ugwoke, M. I., Kaufmann, G., Verbeke, N., & Kinget, R. D. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00434-8 · Cited by 72
Biotransformation Enzymes in the Rodent Nasal Mucosa: The Value of a Histochemical Approach
Bogdanffy, M. S. (1990) · Environmental Health Perspectives · doi:10.2307/3430682 · Cited by 69
Effects of formulation variables on nasal epithelial cell integrity: Biochemical evaluations
Pujara, C. P., Shao, Z., Duncan, M. R., & Mitra, A. K. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00238-z · Cited by 68
Acyclovir Liposomes for Intranasal Systemic Delivery: Development and Pharmacokinetics Evaluation
Alsarra, I. A., Hamed, A. Y., & Alanazi, F. K. (2008) · Drug Delivery · doi:10.1080/10717540802035251 · Cited by 68
Nasal Absorption Enhancers for Biosynthetic Human Growth Hormone in Rats
O’Hagan, D. T., Critchley, H., Farraj, N. F., Fisher, A. N., Johansen, B. R., Davis, S. S., & Illum, L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015884026056 · Cited by 67
The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa
Asai, K., Morishita, M., Katsuta, H., Hosoda, S., Shinomiya, K., Noro, M., Nagai, T., & Takayama, K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00345-9 · Cited by 65
Maestrelli, F., Zerrouk, N., Chemtob, C., & Mura, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.024 · Cited by 64
van den Berg, M. P., Merkus, P., Romeijn, S. G., Verhoef, J. C., & Merkus, F. W. H. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026431.55383.69 · Cited by 64
Stoner, C. L., Cleton, A., Johnson, K., Oh, D.-M., Hallak, H., Brodfuehrer, J., Surendran, N., & Han, H. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.006 · Cited by 63
van den Berg, M. P., Verhoef, J. C., Romeijn, S. G., & Merkus, F. W. H. M. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.02.010 · Cited by 63
Mucoadhesive Polymeric Hydrogels for Nasal Delivery of Acyclovir
Alsarra, I. A., Hamed, A. Y., Mahrous, G. M., Maghraby, G. M. E., Al-Robayan, A. A., & Alanazi, F. K. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802360510 · Cited by 63
Drug Absorption Through Mucosal Membranes: Effect of Mucosal Route and Penetrant Hydrophilicity
Corbo, D. C., Liu, J., & Chien, Y. W. (1989) · Pharmaceutical Research · doi:10.1023/a:1015952320372 · Cited by 62
Effects of proteolytic enzyme inhibitors on nasal absorption of salmon calcitonin in rats
Morimoto, K., Miyazaki, M., & Kakemi, M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00158-2 · Cited by 61
Leonard, A. K., Sileno, A. P., Brandt, G., Foerder, C. A., Quay, S. C., & Costantino, H. R. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.013 · Cited by 61
Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann, J. F. S., Acevedo, R., del Campo, J. M., Pérez, O., & Ferro, V. A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.8.1.103 · Cited by 60
Hussain, M. A., Shenvi, A. B., Rowe, S. M., & Shefter, E. (1989) · Pharmaceutical Research · doi:10.1023/a:1015949013644 · Cited by 59
Muramatsu, K., Maitani, Y., Takayama, K., & Nagai, T. (1999) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102275 · Cited by 59
Direct Nose–Brain Transport of Benzoylecgonine Following Intranasal Administration in Rats
Chow, H. ‐. S., Anavy, N. D., & Villalobos, A. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1122 · Cited by 57
Shao, Z., Park, G., Krishnamoorthy, R., & Mitra, A. K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018903407592 · Cited by 56
Mishima, M., WAKITA, Y., & Nakano, M. (1987) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.10.624 · Cited by 56
A Bovine Parainfluenza Virus Type 3 Vaccine Is Safe and Immunogenic in Early Infancy
Greenberg, D. P., WALKER, R. E., Lee, M., Reisinger, K. S., Ward, J. I., Yogev, R., Blatter, M. M., Yeh, S. H., Karron, R. A., Sangli, C., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428092 · Cited by 54
Rapid-onset intranasal delivery of metoclopramide hydrochloride
Zaki, N. M., Mortada, N. D., Awad, G. A. S., & ElHady, S. S. A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.038 · Cited by 52
Nose-to-brain delivery of tacrine
Jogani, V. V., Shah, P., Misra, A. R., Mishra, P., & Mishra, A. K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.9.0003 · Cited by 52
Stoker, D. G., Reber, K. R., Waltzman, L. S., Ernst, C. C., Hamilton, D. A., Gawarecki, D., Mermelstein, F. H., McNicol, E. D., Wright, C., & Carr, D. B. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00300.x · Cited by 51
Karasulu, E., Yavaşoğlu, A., Evrenşanal, Z., Uyanıkgil, Y., & Karasulu, H. Y. (2008) · Drug Delivery · doi:10.1080/10717540802006377 · Cited by 50
Effect of Cyclodextrins on the Complexation and Nasal Permeation of Melatonin
Babu, R. J., Dayal, P., & Singh, M. S. (2008) · Drug Delivery · doi:10.1080/10717540802006922 · Cited by 49
Evaluation of Enhancers to Increase Nasal Absorption Using Ussing Chamber Technique.
Hosoya, K., Hiroyuki, K. U. B. O., Natsume, H., Sugibayashi, K., & Morimoto, Y. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.316 · Cited by 49
Mucoadhesive microspheres for nasal administration of cyclodextrins
Gavini, E., Rassu, G., Haukvik, T., Lanni, C., Racchi, M., & Giunchedi, P. (2008) · Journal of drug targeting · doi:10.1080/10611860802556842 · Cited by 46
Di-iodo-l-tyrosine-labelled Dextrans as Molecular Size Markers of Nasal Absorption in the Rat
Fisher, A. N., Illum, L., Davis, S. S., & Schacht, E. H. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb05462.x · Cited by 46
Langley, J. M., Halperin, S. A., McNeil, S., SMITH, B., JONES, T., Burt, D. S., Mallett, C. P., Lowell, G. H., & FRIES, L. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.056 · Cited by 46
The Safety and Analgesic Efficacy of Intranasal Ketorolac in Patients with Postoperative Pain
Moodie, J. E., Brown, C., Bisley, E. J., Weber, H. U., & BYNUM, L. J. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318188b736 · Cited by 45
Ekelund, K., Östh, K., Påhlstorp, C., Björk, E., Ulvenlund, S., & Johansson, F. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20283 · Cited by 42
Influence of Liposomes on Tryptic Digestion of Insulin.
Kato, Y., Hosokawa, T., Hayakawa, E., & Ito, K. (1993) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.16.457 · Cited by 41
Rapid-onset intranasal delivery of metoclopramide hydrochloride
Zaki, N. M., Awad, G. A. S., Mortada, N. D., & ElHady, S. S. A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.040 · Cited by 41
ENHANCEMENT OF NASAL ABSORPTION OF CALCITONIN LOADED IN LIPOSOMES
Law, S. L., Huang, K.-J., Chou, V. H. Y., & Cherng, J. (2001) · Journal of Liposome Research · doi:10.1081/lpr-100108460 · Cited by 38
Liposomes based nasal delivery system of nifedipine: Development and characterization
Vyas, S. P., Goswami, S., & Singh, R. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00296-h · Cited by 37
Anti-inflammatory Effect from Indomethacin Nanoparticles Inhaled by Male Mice
Onischuk, A. A., Толстикова, Т. Г., Sorokina, I. V., Жукова, Н. А., Baklanov, A. M., Karasev, V. V., Dultseva, G. G., Болдырев, В. В., & Fomin, V. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2007.0672 · Cited by 36
Mucosal vaccination against bacterial respiratory infections
Baumann, U. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.8.1257 · Cited by 36
Intranasal administration of acetylcholinesterase inhibitors
Costantino, H. R., Leonard, A. K., Brandt, G., Johnson, P. H., & Quay, S. C. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s6 · Cited by 36
Carbopol-Based Gels for Nasal Delivery of Progesterone
Rathnam, G., Narayanan, N., & Ilavarasan, R. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9144-7 · Cited by 35
Pharmacokinetics of Substrate Uptake and Distribution in Murine Brain After Nasal Instillation
Graff, C. L., Zhao, R., & Pollack, G. M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1191-5 · Cited by 33
Yang, Z., Huang, Y., Gan, G., & Sawchuk, R. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20334 · Cited by 33
Simon, M., Wittmar, M., Kissel, T., & Linn, T. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7676-z · Cited by 32
Furubayashi, T., Kamaguchi, A., 河原田, 一., Masaoka, Y., Kataoka, M., Yamashita, S., Higashi, Y., & Sakane, T. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.608 · Cited by 32
A novel and effective approach to treating rhinitis with nasal antihistamines
Kaliner, M. (2007) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60560-1 · Cited by 31
Characterization of human nasal primary culture systems to investigate peptide metabolism
Hoang, V. D., Agu, R. U., Jorissen, M., Renaat, K., & Verbeke, N. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00077-7 · Cited by 31
Development of a Cyclodextrin-Based Nasal Delivery System for Lorazepam
Jug, M., & Bećirević‐Laćan, M. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040801926063 · Cited by 31
Kandimalla, K. K., & Donovan, M. D. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.012 · Cited by 30
Goblet Cells Secretion And Mucogenesis
Verdugo, P. (1990) · Annual Review of Physiology · doi:10.1146/annurev.physiol.52.1.157 · Cited by 26
The Clinical Applications of Intranasal Opioids
Paech, M. J., & Shelley, K. (2008) · Current Drug Delivery · doi:10.2174/156720108783330989 · Cited by 26
Wang, H., HUSSAIN, A. A., & Wedlund, P. J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2491-0 · Cited by 26
Nose-to-brain delivery of TS-002, prostaglandin D2 analogue
Yamada, K., Hasegawa, M., Kametani, S., & Ito, S. (2007) · Journal of drug targeting · doi:10.1080/10611860601029496 · Cited by 26
Ding, W., Qi, X., Fu, Q., & Hui-shan, P. (2007) · Drug Delivery · doi:10.1080/10717540600740102 · Cited by 26
HUSSAIN, A. A., Al-Bayatti, A. A., Dakkuri, A., Okochi, K., & Hussain, M. A. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10083 · Cited by 24
Transport Characteristics of a Beta Sheet Breaker Peptide Across Excised Bovine Nasal Mucosa
Greimel, A., Bernkop‐Schnürch, A., Curto, M. D. D., & D'Antonio, M. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600712953 · Cited by 24
Bråve, A., Hallengärd, D., Schröder, U., Blomberg, P., Wahrén, B., & Hinkula, J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.066 · Cited by 23
Distribution of nimodipine in brain following intranasal administration in rats.
Zhang, Q., Jiang, X., & Wu, C. (2004) · PubMed · Cited by 23
The role of tracheobronchial mucus in drug administration to the airways
Lethem, M. I. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90013-t · Cited by 21
Intranasal hormone replacement therapy
Wattanakumtornkul, S., Pinto, A., & Williams, D. B. (2003) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200310010-00014 · Cited by 20
Machida, M., Sano, K., Arakawa, M., Hayashi, M., & Awazu, S. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.1375 · Cited by 19
Leykin, Y., Casati, A., Rapotec, A., Sasso, M., Barzan, L., Fanelli, G. C., & Pellis, T. (2008) · PubMed · Cited by 18
Chronic Rhinosinusitis and Biofilms
Ramadan, H. H., Sanclement, J. A., & Thomas, J. G. (2004) · Otolaryngology · doi:10.1016/j.otohns.2004.06.072 · Cited by 18
Kilian, N., & Müller, D. G. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00364-5 · Cited by 16
Nasal Absorption of Interferon: Enhancement by Surfactant Agents
Baglioni, C., & Rj, P. (1990) · Journal of Interferon Research · doi:10.1089/jir.1990.10.497 · Cited by 13
Mollee, H., Steenvoorden, D. P. T., de Vringer, T., & Crommelin, D. J. A. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200105)90:5<617::aid-jps1018>3.0.co;2-5 · Cited by 7
Drabick, J. J., Brandt, B. L., Moran, E. E., Saunders, N. B., & Shoemaker, D. R. (1998) · Defense Technical Information Center (DTIC) · doi:10.21236/ada369066 · Cited by 6
Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir
Yang, C., Gao, H., & Mitra, A. K. (2001) · Journal of Pharmaceutical Sciences · Cited by 5
Intranasal hormone replacement therapy
Wattanakumtornkul, S., Pinto, A., & Williams, D. B. (2003) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200301000-00014 · Cited by 4
Research works printed but not linked: 5
- [27]27. Stevens A., Lowe J., Human histology, Mosby, Philadelphia, USA, 1997.
- [35]35. Dae-Duk Ki, Drug Absorption Studies: In situ, In vitro and In silico models, chapter 9, Springer, USA, 2007.
- [56]56. Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv, 2006; 13:31-38.
- [72]72. Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus in infants and young children. J Infect Dis, 2004; 190:2096-2103.
- [113]113. Hussain A.A., Bawarshi-Nassar R., Huang C.H., Transnasal Systemic Medications. Elsevier, Amsterdam, 1985. 123.
Cited by
Mechanism of intranasal drug delivery directly to the brain
Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G., & Hsu, W. H. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.025 · Cited by 721
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Aryal, M., Arvanitis, C. D., Alexander, P. M., & McDannold, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.008 · Cited by 443
Intranasal drug delivery: An efficient and non-invasive route for systemic administration
Grassin-Delyle, S., Buenestado, A., Naline, E., Faisy, C., Blouquit-Laye, S., Couderc, L.-J., Le Guen, M., Fischler, M., & Devillier, P. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.003 · Cited by 398
Metadata
- Authors
- Pires, A., Fortuna, A., Alves, G., & Falcão, A.
- Affiliations
- University of Coimbra (PT)
- University of Beira Interior (PT)
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2009-10-12
- Volume
- 12
- Issue
- 3
- Pages
- 288
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W2106536537
- Cited by
- 641
- References
- 175
- Citations by year
- 2026: 31 · 2025: 49 · 2024: 44 · 2023: 45 · 2022: 67 · 2021: 65 · 2020: 48 · 2019: 41 · 2018: 35 · 2017: 42 · 2016: 35 · 2015: 29 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Pharmacy & Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-sa)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/45145/2008)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, nasal mucosa, transmucosal drug absorption, brain drug delivery, topical drug delivery, systemic drug delivery
- MeSH terms
- Absorption, Administration, Intranasal, Animals, Biological Availability, Humans, Nasal Cavity, Nasal Mucosa, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.